Babiec L, Wilkaniec A, Matuszewska M, Palasz E, Cieslik M, Adamczyk A
Brain Sci. 2023; 13(7).
PMID: 37509018
PMC: 10377192.
DOI: 10.3390/brainsci13071088.
Vellingiri B, Venkatesan D, Iyer M, Mohan G, Krishnan P, Krishna K
J Mol Neurosci. 2023; 73(4-5):214-224.
PMID: 36930427
DOI: 10.1007/s12031-023-02111-4.
Guo M, Xie P, Liu S, Luan G, Li T
Curr Neuropharmacol. 2022; 21(1):54-66.
PMID: 35794774
PMC: 10193761.
DOI: 10.2174/1570159X20666220706100136.
Murugan M, Fedele D, Millner D, Alharfoush E, Vegunta G, Boison D
Neurochem Int. 2021; 147:105054.
PMID: 33961946
PMC: 8178237.
DOI: 10.1016/j.neuint.2021.105054.
Gebril H, Wahba A, Zhou X, Lai T, Alharfoush E, DiCicco-Bloom E
eNeuro. 2021; 8(3).
PMID: 33863781
PMC: 8174006.
DOI: 10.1523/ENEURO.0011-21.2021.
Adenosine kinase inhibition promotes proliferation of neural stem cells after traumatic brain injury.
Gebril H, Rose R, Gesese R, Emond M, Huo Y, Aronica E
Brain Commun. 2020; 2(1):fcaa017.
PMID: 32322821
PMC: 7158236.
DOI: 10.1093/braincomms/fcaa017.
From Cannabinoids and Neurosteroids to Statins and the Ketogenic Diet: New Therapeutic Avenues in Rett Syndrome?.
Mouro F, Miranda-Lourenco C, Sebastiao A, Diogenes M
Front Neurosci. 2019; 13:680.
PMID: 31333401
PMC: 6614559.
DOI: 10.3389/fnins.2019.00680.
Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature.
Kovacs Z, DAgostino D, Diamond D, Kindy M, Rogers C, Ari C
Front Psychiatry. 2019; 10:363.
PMID: 31178772
PMC: 6543248.
DOI: 10.3389/fpsyt.2019.00363.
Adenosine Actions on Oligodendroglia and Myelination in Autism Spectrum Disorder.
Shen H, Huang N, Reemmer J, Xiao L
Front Cell Neurosci. 2018; 12:482.
PMID: 30581380
PMC: 6292987.
DOI: 10.3389/fncel.2018.00482.
Developmental role of adenosine kinase for the expression of sex-dependent neuropsychiatric behavior.
Osborne D, Sandau U, Jones A, Vander Velden J, Weingarten A, Etesami N
Neuropharmacology. 2018; 141:89-97.
PMID: 30145320
PMC: 6867705.
DOI: 10.1016/j.neuropharm.2018.08.025.
Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases.
Fumagalli M, Lecca D, Abbracchio M, Ceruti S
Front Pharmacol. 2018; 8:941.
PMID: 29375373
PMC: 5770749.
DOI: 10.3389/fphar.2017.00941.
Purinergic Signalling: Therapeutic Developments.
Burnstock G
Front Pharmacol. 2017; 8:661.
PMID: 28993732
PMC: 5622197.
DOI: 10.3389/fphar.2017.00661.
Purinergic system in psychiatric diseases.
Cheffer A, Castillo A, Correa-Velloso J, Goncalves M, Naaldijk Y, Nascimento I
Mol Psychiatry. 2017; 23(1):94-106.
PMID: 28948971
DOI: 10.1038/mp.2017.188.
Role of Ectonucleotidases in Synapse Formation During Brain Development: Physiological and Pathological Implications.
Grkovic I, Drakulic D, Martinovic J, Mitrovic N
Curr Neuropharmacol. 2017; 17(1):84-98.
PMID: 28521702
PMC: 6341498.
DOI: 10.2174/1570159X15666170518151541.
Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches.
Cheng N, Rho J, Masino S
Front Mol Neurosci. 2017; 10:34.
PMID: 28270747
PMC: 5318388.
DOI: 10.3389/fnmol.2017.00034.
Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder.
Ruskin D, Murphy M, Slade S, Masino S
PLoS One. 2017; 12(2):e0171643.
PMID: 28166277
PMC: 5293204.
DOI: 10.1371/journal.pone.0171643.
Analysis of Extracellular Nucleotide Metabolism in Adult Zebrafish After Embryological Exposure to Valproic Acid.
Zimmermann F, Gaspary K, Siebel A, Leite C, Kist L, Bogo M
Mol Neurobiol. 2016; 54(5):3542-3553.
PMID: 27189619
DOI: 10.1007/s12035-016-9917-z.
GWAS and transcriptional analysis prioritize ITPR1 and CNTN4 for a serum uric acid 3p26 QTL in Mexican Americans.
Chittoor G, Kent Jr J, Almeida M, Puppala S, Farook V, Cole S
BMC Genomics. 2016; 17:276.
PMID: 27039371
PMC: 4818944.
DOI: 10.1186/s12864-016-2594-5.
Adenosine receptors and epilepsy: current evidence and future potential.
Masino S, Kawamura Jr M, Ruskin D
Int Rev Neurobiol. 2014; 119:233-55.
PMID: 25175969
PMC: 6026023.
DOI: 10.1016/B978-0-12-801022-8.00011-8.
Ketogenic diet improves core symptoms of autism in BTBR mice.
Ruskin D, Svedova J, Cote J, Sandau U, Rho J, Kawamura Jr M
PLoS One. 2013; 8(6):e65021.
PMID: 23755170
PMC: 3673987.
DOI: 10.1371/journal.pone.0065021.